Cargando…
Two novel ECHS1 variants, affecting splicing and reducing enzyme activity, is associated with mitochondrial encephalopathy in infant: a case report
BACKGROUND: Short-chain enoyl-CoA hydratase (ECHS1) is a multifunctional mitochondrial matrix enzyme involved in the second step of mitochondrial fatty acid β-oxidation. Mitochondrial diseases resulting from ECHS1 mutations are often characterised by encephalopathy, deafness, epilepsy, optic atrophy...
Autores principales: | Wu, Miaojuan, Gao, Wenqi, Deng, Zhifang, Liu, Zhisheng, Ma, Jiehui, Xiao, Han, Xu, Yu, Sun, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193542/ https://www.ncbi.nlm.nih.gov/pubmed/32354323 http://dx.doi.org/10.1186/s12883-020-01735-y |
Ejemplares similares
-
Deficiency of ECHS1 causes mitochondrial encephalopathy with cardiac involvement
por: Haack, Tobias B, et al.
Publicado: (2015) -
Novel ECHS1 mutations in Leigh syndrome identified by whole-exome sequencing in five Chinese families: case report
por: Sun, Dan, et al.
Publicado: (2020) -
Emerging evidence of genotype–phenotype associations of developmental and epileptic encephalopathy due to KCNC2 mutation: Identification of novel R405G
por: Wang, Sumei, et al.
Publicado: (2022) -
Epigenetic Regulation of Heart-ECHS
por: Gan, Lu, et al.
Publicado: (2022) -
An elementary alternative to ECH capacities
por: Hutchings, Michael
Publicado: (2022)